JP2005087520A - 薬液注入装置 - Google Patents
薬液注入装置 Download PDFInfo
- Publication number
- JP2005087520A JP2005087520A JP2003326022A JP2003326022A JP2005087520A JP 2005087520 A JP2005087520 A JP 2005087520A JP 2003326022 A JP2003326022 A JP 2003326022A JP 2003326022 A JP2003326022 A JP 2003326022A JP 2005087520 A JP2005087520 A JP 2005087520A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- needle
- holding body
- container
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 239000007788 liquid Substances 0.000 title claims abstract description 34
- 230000000149 penetrating effect Effects 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims description 106
- 239000000243 solution Substances 0.000 claims description 88
- 239000007924 injection Substances 0.000 claims description 60
- 238000002347 injection Methods 0.000 claims description 60
- 229940079593 drug Drugs 0.000 claims description 52
- 239000012790 adhesive layer Substances 0.000 claims description 19
- 238000003825 pressing Methods 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000013013 elastic material Substances 0.000 claims description 4
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 210000003491 skin Anatomy 0.000 description 98
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 28
- 239000010410 layer Substances 0.000 description 20
- 102000004877 Insulin Human genes 0.000 description 14
- 108090001061 Insulin Proteins 0.000 description 14
- 229940125396 insulin Drugs 0.000 description 14
- 210000004207 dermis Anatomy 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 239000008155 medical solution Substances 0.000 description 10
- -1 polypropylene Polymers 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000001339 epidermal cell Anatomy 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 206010033675 panniculitis Diseases 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 210000004003 subcutaneous fat Anatomy 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 102000055006 Calcitonin Human genes 0.000 description 2
- 108060001064 Calcitonin Proteins 0.000 description 2
- 102000018997 Growth Hormone Human genes 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960004015 calcitonin Drugs 0.000 description 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010073753 Fear of injection Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229910000639 Spring steel Inorganic materials 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940035678 anti-parkinson drug Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 229940124433 antimigraine drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 229940125388 beta agonist Drugs 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 108091008708 free nerve endings Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- BYMJQPSBSTWSGH-UHFFFAOYSA-N humarin Natural products OCC1OC(OCC2OC(OC(=O)c3cc(O)c(O)c(O)c3)C(O)C(O)C2O)C(O)C(O)C1OC(=O)c4cc(O)c(O)c(O)c4 BYMJQPSBSTWSGH-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000000734 parasympathomimetic agent Substances 0.000 description 1
- 229940127242 parasympathomimetic drug Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940127230 sympathomimetic drug Drugs 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229940100640 transdermal system Drugs 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003326022A JP2005087520A (ja) | 2003-09-18 | 2003-09-18 | 薬液注入装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003326022A JP2005087520A (ja) | 2003-09-18 | 2003-09-18 | 薬液注入装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005087520A true JP2005087520A (ja) | 2005-04-07 |
| JP2005087520A5 JP2005087520A5 (enrdf_load_stackoverflow) | 2006-10-19 |
Family
ID=34456319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003326022A Pending JP2005087520A (ja) | 2003-09-18 | 2003-09-18 | 薬液注入装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005087520A (enrdf_load_stackoverflow) |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009093240A (ja) * | 2007-10-04 | 2009-04-30 | Hitachi Ltd | Ｒｆタグと個体識別番号との紐付け方法 |
| US7740600B2 (en) | 2002-08-02 | 2010-06-22 | Candela Corporation | Apparatus and method for inhibiting pain signals transmitted during a skin related medical treatment |
| US7740651B2 (en) | 2007-09-28 | 2010-06-22 | Candela Corporation | Vacuum assisted treatment of the skin |
| US7762965B2 (en) | 2001-12-10 | 2010-07-27 | Candela Corporation | Method and apparatus for vacuum-assisted light-based treatments of the skin |
| US7762964B2 (en) | 2001-12-10 | 2010-07-27 | Candela Corporation | Method and apparatus for improving safety during exposure to a monochromatic light source |
| US7771374B2 (en) | 2001-12-10 | 2010-08-10 | Candela Corporation | Method and apparatus for vacuum-assisted light-based treatments of the skin |
| US7935139B2 (en) | 2001-12-10 | 2011-05-03 | Candela Corporation | Eye safe dermatological phototherapy |
| US8123699B2 (en) | 2007-09-04 | 2012-02-28 | Lyon Thomas R | Method and apparatus for aspiration |
| KR101305539B1 (ko) | 2012-02-16 | 2013-09-06 | (주)메가메디칼 | 약물주사용 건 |
| CN104587562A (zh) * | 2014-12-26 | 2015-05-06 | 杨力 | 心绞痛自救针 |
| JP2015091453A (ja) * | 2010-02-01 | 2015-05-14 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | 低用量で事前充填式の薬剤送達デバイス |
| WO2015105162A1 (ja) * | 2014-01-08 | 2015-07-16 | ニプロ株式会社 | 中空針および中空針の製造方法 |
| JP2017533774A (ja) * | 2014-11-14 | 2017-11-16 | サイトレリス バイオシステムズ，インコーポレーテッド | 皮膚のアブレーションのためのデバイス及び方法 |
| WO2018056403A1 (ja) * | 2016-09-23 | 2018-03-29 | テルモ株式会社 | 医療器具及び投与方法 |
| AU2016220141B2 (en) * | 2015-02-17 | 2018-07-12 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
| US10390753B2 (en) | 2014-10-21 | 2019-08-27 | Alltest Gmbh | Blister strip |
| US10595760B2 (en) | 2015-05-05 | 2020-03-24 | University Of Massachusetts | Compliant syringe system, a method of making, and of using the same |
| US10953143B2 (en) | 2013-12-19 | 2021-03-23 | Cytrellis Biosystems, Inc. | Methods and devices for manipulating subdermal fat |
| KR102247709B1 (ko) * | 2020-08-06 | 2021-05-07 | 이민우 | 주사액 주사장치 |
| US11166743B2 (en) | 2016-03-29 | 2021-11-09 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
| US11464954B2 (en) | 2016-09-21 | 2022-10-11 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
| US11534344B2 (en) | 2013-02-20 | 2022-12-27 | Cytrellis Biosystems, Inc. | Methods and devices for skin tightening |
| US12150671B2 (en) | 2013-08-09 | 2024-11-26 | Cytrellis Biosystems, Inc. | Methods and apparatuses for skin treatment using non-thermal tissue ablation |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5695058A (en) * | 1979-12-10 | 1981-08-01 | Toyo Jozo Kk | Microosyringe |
| JPH08508901A (ja) * | 1993-04-08 | 1996-09-24 | イーラン・メディカル・テクノロジーズ・リミテッド | 皮内注入装置 |
| JPH09504974A (ja) * | 1993-11-18 | 1997-05-20 | イーラン・メディカル・テクノロジーズ・リミテッド | 皮膚内薬剤給送装置 |
| JP2002291884A (ja) * | 2001-01-25 | 2002-10-08 | Terumo Corp | 液体注入針および液体注入装置 |
-
2003
- 2003-09-18 JP JP2003326022A patent/JP2005087520A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5695058A (en) * | 1979-12-10 | 1981-08-01 | Toyo Jozo Kk | Microosyringe |
| JPH08508901A (ja) * | 1993-04-08 | 1996-09-24 | イーラン・メディカル・テクノロジーズ・リミテッド | 皮内注入装置 |
| JPH09504974A (ja) * | 1993-11-18 | 1997-05-20 | イーラン・メディカル・テクノロジーズ・リミテッド | 皮膚内薬剤給送装置 |
| JP2002291884A (ja) * | 2001-01-25 | 2002-10-08 | Terumo Corp | 液体注入針および液体注入装置 |
Cited By (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7935139B2 (en) | 2001-12-10 | 2011-05-03 | Candela Corporation | Eye safe dermatological phototherapy |
| US7771374B2 (en) | 2001-12-10 | 2010-08-10 | Candela Corporation | Method and apparatus for vacuum-assisted light-based treatments of the skin |
| US7762965B2 (en) | 2001-12-10 | 2010-07-27 | Candela Corporation | Method and apparatus for vacuum-assisted light-based treatments of the skin |
| US7762964B2 (en) | 2001-12-10 | 2010-07-27 | Candela Corporation | Method and apparatus for improving safety during exposure to a monochromatic light source |
| US7740600B2 (en) | 2002-08-02 | 2010-06-22 | Candela Corporation | Apparatus and method for inhibiting pain signals transmitted during a skin related medical treatment |
| US8123699B2 (en) | 2007-09-04 | 2012-02-28 | Lyon Thomas R | Method and apparatus for aspiration |
| US8986220B2 (en) | 2007-09-04 | 2015-03-24 | Thomas R. Lyon | Spinal aspiration apparatus |
| US9078693B2 (en) | 2007-09-04 | 2015-07-14 | Thomas R. Lyon | Method and apparatus for aspiration |
| US7740651B2 (en) | 2007-09-28 | 2010-06-22 | Candela Corporation | Vacuum assisted treatment of the skin |
| JP2009093240A (ja) * | 2007-10-04 | 2009-04-30 | Hitachi Ltd | Ｒｆタグと個体識別番号との紐付け方法 |
| US11738150B2 (en) | 2010-02-01 | 2023-08-29 | Becton, Dickinson And Company | Low dose prefilled drug delivery device and method |
| US9849247B2 (en) | 2010-02-01 | 2017-12-26 | Becton, Dickinson And Company | Low dose prefilled drug delivery device and method |
| JP2015091453A (ja) * | 2010-02-01 | 2015-05-14 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | 低用量で事前充填式の薬剤送達デバイス |
| US10898648B2 (en) | 2010-02-01 | 2021-01-26 | Becton, Dickinson And Company | Low dose prefilled drug delivery device and method |
| KR101305539B1 (ko) | 2012-02-16 | 2013-09-06 | (주)메가메디칼 | 약물주사용 건 |
| US12023226B2 (en) | 2013-02-20 | 2024-07-02 | Cytrellis Biosystems, Inc. | Methods and devices for skin tightening |
| US11534344B2 (en) | 2013-02-20 | 2022-12-27 | Cytrellis Biosystems, Inc. | Methods and devices for skin tightening |
| US12150671B2 (en) | 2013-08-09 | 2024-11-26 | Cytrellis Biosystems, Inc. | Methods and apparatuses for skin treatment using non-thermal tissue ablation |
| US10953143B2 (en) | 2013-12-19 | 2021-03-23 | Cytrellis Biosystems, Inc. | Methods and devices for manipulating subdermal fat |
| JP2015147042A (ja) * | 2014-01-08 | 2015-08-20 | ニプロ株式会社 | 中空針および中空針の製造方法 |
| WO2015105162A1 (ja) * | 2014-01-08 | 2015-07-16 | ニプロ株式会社 | 中空針および中空針の製造方法 |
| US10390753B2 (en) | 2014-10-21 | 2019-08-27 | Alltest Gmbh | Blister strip |
| US11497434B2 (en) | 2014-10-21 | 2022-11-15 | Alltest Gmbh | Blister strip |
| JP2017533774A (ja) * | 2014-11-14 | 2017-11-16 | サイトレリス バイオシステムズ，インコーポレーテッド | 皮膚のアブレーションのためのデバイス及び方法 |
| US12256957B2 (en) | 2014-11-14 | 2025-03-25 | Cytrellis Biosystems, Inc. | Devices and methods for ablation of the skin |
| US11896261B2 (en) | 2014-11-14 | 2024-02-13 | Cytrellis Biosystems, Inc. | Devices and methods for ablation of the skin |
| US11324534B2 (en) | 2014-11-14 | 2022-05-10 | Cytrellis Biosystems, Inc. | Devices and methods for ablation of the skin |
| CN104587562A (zh) * | 2014-12-26 | 2015-05-06 | 杨力 | 心绞痛自救针 |
| AU2016220141B2 (en) * | 2015-02-17 | 2018-07-12 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
| US11517663B2 (en) | 2015-02-17 | 2022-12-06 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
| US10583245B2 (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
| US10595760B2 (en) | 2015-05-05 | 2020-03-24 | University Of Massachusetts | Compliant syringe system, a method of making, and of using the same |
| US11166743B2 (en) | 2016-03-29 | 2021-11-09 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
| US11464954B2 (en) | 2016-09-21 | 2022-10-11 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
| WO2018056403A1 (ja) * | 2016-09-23 | 2018-03-29 | テルモ株式会社 | 医療器具及び投与方法 |
| KR102247709B1 (ko) * | 2020-08-06 | 2021-05-07 | 이민우 | 주사액 주사장치 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4409239B2 (ja) | 薬液注入装置 | |
| JP2005087520A (ja) | 薬液注入装置 | |
| EP1757240B1 (en) | Valved intradermal delivery device | |
| US8652095B2 (en) | Skin retention device for a medical jet injection kit | |
| US7998119B2 (en) | System and method for delivering fluid into flexible biological barrier | |
| CN100509072C (zh) | 皮内注射装置 | |
| JP4286897B2 (ja) | 注射器として使用できるアンプル、及び注射器ユニット | |
| EP2531242B1 (en) | Dermal access device | |
| US8007466B2 (en) | System and method for delivering fluid into flexible biological barrier | |
| CN102369034A (zh) | 注射针组合体及药剂注射装置 | |
| US20090247953A1 (en) | Microneedle adaptor for dosed drug delivery devices | |
| JPWO2007052662A1 (ja) | 穿刺器具、投与器具及び穿刺方法 | |
| JP2012100783A (ja) | 薬液供給装置 | |
| US20250256034A1 (en) | Medical Agent Dispensing Apparatuses, Systems, and Methods | |
| US8876764B2 (en) | Intradermal pen adapter | |
| JP2005087521A (ja) | 薬液注入装置 | |
| US20150038911A1 (en) | Microneedle adapter for dosed drug delivery devices | |
| WO2004006996A1 (ja) | 注射針および導液具 | |
| CN115887101B (zh) | 一种眼科注射用的注射装置及其应用 | |
| JP2011045565A (ja) | 薬液注入装置 | |
| CN115867337A (zh) | 适配器和注射器 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060906 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060906 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090924 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090929 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091130 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100413 |